In another Mayo Clinic study of the same cohort, statins were associated with a decreased risk of lower urinary tract symptoms and benign prostatic enlargement, as well as a decreased peak urinary flow rate. The combined use of statins and NSAIDs lowered these risks further, Dr. Jennifer L. St. Sauver, also of the Mayo Clinic, and her colleagues reported in a poster.
Dr. St. Sauver had no financial disclosures related to the study. Dr. Nehra is a consultant for Pfizer, GlaxoSmithKline, and Sanofi-Aventis.